LncRNA AC100826.1 regulated PLCB1 to promote progression in non-small cell lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Lung cancer remains a leading cause of cancer mortality worldwide.
• Non-small cell lung cancer (NSCLC) is the most prevalent histological subtype.
• Identifying novel molecular targets is crucial for improving NSCLC treatment outcomes.

Purpose of the Study:

• To identify and characterize novel long non-coding RNAs (lncRNAs) involved in NSCLC progression.
• To elucidate the role of a specific lncRNA, AC100826.1 (Lnc1), in NSCLC cell proliferation and metastasis.
• To investigate the underlying molecular mechanisms, including signaling pathways, regulated by Lnc1 in NSCLC.

Main Methods:

• RNA sequencing was employed to identify differentially expressed lncRNAs in NSCLC tissues.
• In vitro assays (CCK-8, transwell, scratch) assessed the impact of Lnc1 on NSCLC cell proliferation, invasion, and migration.
• In vivo xenograft models were utilized to confirm Lnc1's effects on tumor growth and metastasis.
• RT-qPCR and Western blotting were used to validate mRNA and protein expression levels.

Main Results:

• Lnc1 was found to be highly expressed in NSCLC tissues and correlated with pathological parameters.
• Knockdown of Lnc1 significantly inhibited NSCLC cell proliferation and metastasis in vitro and in vivo.
• Overexpression of Lnc1 promoted NSCLC cell proliferation and migration, effects reversed by silencing phospholipase C, β1 (PLCB1).
• The PLCB1/Rap1 signaling pathway was identified as a key mediator of Lnc1's function in NSCLC metastasis.

Conclusions:

• Lnc1 plays a critical role in promoting NSCLC cell proliferation and metastasis.
• Lnc1 exerts its oncogenic effects by targeting the PLCB1/Rap1 signaling pathway.
• Lnc1 represents a potential therapeutic target for managing NSCLC progression and metastasis.